<span style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; line-height: normal;">In Ecuador, is conducting a clinical trial of the new Cuban medication Heberprot-P, which is used to treat ulcerative lesions of the lower limbs of diabetics and reduce the number of amputations. Cuban and Ecuadorian specialists work together to evaluate the results.</span>
Read More